✦ LIBER ✦

Editorial Comment on: Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study

✍ Scribed by Sergio Bracarda

Book ID: 113609875
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 71 KB
Volume: 52
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2007.01.105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly Docetaxel and Prednisolone versus

Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study

✍ Sophie D. Fosså; Anne-Birgitte Jacobsen; Claes Ginman; Inga N. Jacobsen; Sissel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB

A RANDOMIZED, PHASE II TRIAL OF KETOCONA

A RANDOMIZED, PHASE II TRIAL OF KETOCONAZOLE PLUS ALENDRONATE VERSUS KETOCONAZOLE ALONE IN PATIENTS WITH ANDROGEN INDEPENDENT PROSTATE CANCER AND BONE METASTASES

✍ FIGG, W; LIU, Y; ARLEN, P; GULLEY, J; STEINBERG, S; LIEWEHR, D; COX, M; ZHAI, S; 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 474 KB

A randomized, phase II trial of ketocona

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases: Figg WD, Liu Y, Arlen P, Gulley J, Steinberg SM, Liewehr DJ, Cox MC, Zhai S, Cremers S, Parr A, Yang X, Chen CC, Jones E, Dahut WL, Center for Cancer Research, National Cancer Institute, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD

✍ Donald L. Trump 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB